NCT02906462

Brief Summary

In 2003, MAHO study (Ferrand E, Jabre P, Vincent-Genod C, et al. Circumstances of death in hospitalized patients and nurses' perceptions: French multicenter Mort-a-l'Hôpital survey. Arch Intern Med. 2008 168: 867-875.) evaluated the way 3793 patients died in 200 French hospitals and showed that their conditions of death were not optimal. The 22th April 2005 French Law precised patient's end of life rights with necessity to refrain from any unreasonable obstinacy, the right to refuse treatments and the obligation of a collegial process decision when the patient is not conscious. Since then, studies haven't demonstrate any improvement and found that palliative strategy in France is much less used than in other developed countries.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

23 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2013

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

February 17, 2016

Completed
7 months until next milestone

First Posted

Study publicly available on registry

September 20, 2016

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2019

Completed
Last Updated

May 17, 2019

Status Verified

May 1, 2019

Enrollment Period

5.3 years

First QC Date

February 17, 2016

Last Update Submit

May 15, 2019

Conditions

Keywords

Leonetti French lawPalliative care

Outcome Measures

Primary Outcomes (1)

  • Rate of withdraw/withhold of treatment in each group

    To evaluate the impact of an early palliative strategy using vulnerability criteria compared to standard care.

    From hospital admission to death or discharge or 9 months after inclusion if the patient is still in the hospital

Secondary Outcomes (4)

  • Death conditions

    From hospital admission to death or discharge or 9 months after inclusion if the patient is still in the hospital

  • Early vulnerability consideration impact on length of stay

    From hospital admission to death or discharge or 9 months after inclusion if the patient is still in the hospital

  • Palliative strategy modalities

    From hospital admission to death or discharge or 9 months after inclusion if the patient is still in the hospital

  • Early vulnerability consideration impact on caregivers' satisfaction

    From hospital admission to death or discharge or 9 months after inclusion if the patient is still in the hospital

Study Arms (2)

Usual Practices

OTHER

Usual Practices

Other: Usual practices

Early consideration of vulnerability

OTHER

Strategy promoting early consideration of patients' vulnerability

Other: Early consideration of vulnerability

Interventions

One day training with the provision of vulnerability criteria inciting an early reflection of the level of therapeutic engagement; sheets available on the internet computer support collegial reflection and traceability of decisions to limit and stop treatments, incorporating the provisions of law known Leonetti

Early consideration of vulnerability

the centres applies their usual practices

Usual Practices

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient more than 18 years old hospitalized for at least 24h and who's prognosis (survival or quality of life) should lead to a palliative approach
  • Patient suffering with at least one of the following vulnerability criteria will be included:
  • Evolutive and symptomatic incurable cancer
  • Aged more than 75 years old and presenting several geriatric syndromes (cognitive disorders, isolation, malnutrition, bedridden more than 12h per day)
  • Neurologic pathology, chronic, with loss of autonomy (Performance Status\>3)
  • Final organ failure (heart, lungs, liver, kidney) with loss of autonomy (Performance Status\>3)
  • Care refusal and/or expressed will to die or repeated request for help to die

You may not qualify if:

  • Minors
  • Patients without indication for treatment or surveillance with length of stay inferior to 24h
  • Brain dead patients
  • Not consent patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (23)

CHU

Amiens, 80000, France

Location

Hopital privé Oncologie Médicale

Antony, 92160, France

Location

Hôpital Privé Medecine interne

Antony, 92160, France

Location

Hôpital Avicenne

Bobigny, 93000, France

Location

Hôpital Ambroise Paré

Boulogne-Billancourt, 92100, France

Location

Hôpital Georges Clemenceau

Champcueil, 91750, France

Location

CHU

Dijon, 21000, France

Location

Centre Hospitalier

Épernay, 51200, France

Location

Hôpital Bicêtre

Le Kremlin-Bicêtre, 94270, France

Location

CHRU

Lille, 59000, France

Location

Hopital Lariboisiere Medecine interne

Paris, 75010, France

Location

Groupe Hospitalier Paris - Saint-Joseph

Paris, 75014, France

Location

Hopital Cochin Gastro-Enterologie

Paris, 75014, France

Location

Centre Hospitalier Universitaire

Poitiers, 86000, France

Location

Centre Hospitalier

Roubaix, 59100, France

Location

Centre Hospitalier de Soissons

Soissons, 02200, France

Location

Hiopital Foch Néphrologie

Suresnes, 92150, France

Location

Hopital Foch Cardiologie

Suresnes, 92150, France

Location

Hopital Foch Chirurgie Urologique

Suresnes, 92150, France

Location

Hopital Foch Médecine Interne

Suresnes, 92150, France

Location

Hopital Foch Neurochirurgie

Suresnes, 92150, France

Location

Hopîtal Foch Urgences

Suresnes, 92150, France

Location

CH

Valenciennes, 59300, France

Location

Related Publications (12)

  • Truog RD, Cist AF, Brackett SE, Burns JP, Curley MA, Danis M, DeVita MA, Rosenbaum SH, Rothenberg DM, Sprung CL, Webb SA, Wlody GS, Hurford WE. Recommendations for end-of-life care in the intensive care unit: The Ethics Committee of the Society of Critical Care Medicine. Crit Care Med. 2001 Dec;29(12):2332-48. doi: 10.1097/00003246-200112000-00017. No abstract available.

    PMID: 11801837BACKGROUND
  • Ferrand E, Jabre P, Vincent-Genod C, Aubry R, Badet M, Badia P, Cariou A, Ellien F, Gounant V, Gil R, Jaber S, Jay S, Paillaud E, Poulain P, Regnier B, Reignier J, Socie G, Tardy B, Lemaire F, Brun-Buisson C, Marty J; French Mort-a-l'Hopital Group. Circumstances of death in hospitalized patients and nurses' perceptions: French multicenter Mort-a-l'Hopital survey. Arch Intern Med. 2008 Apr 28;168(8):867-75. doi: 10.1001/archinte.168.8.867.

  • Ferrand E, Robert R, Ingrand P, Lemaire F; French LATAREA Group. Withholding and withdrawal of life support in intensive-care units in France: a prospective survey. French LATAREA Group. Lancet. 2001 Jan 6;357(9249):9-14. doi: 10.1016/s0140-6736(00)03564-9.

  • Ferrand E, Lemaire F, Regnier B, Kuteifan K, Badet M, Asfar P, Jaber S, Chagnon JL, Renault A, Robert R, Pochard F, Herve C, Brun-Buisson C, Duvaldestin P; French RESSENTI Group. Discrepancies between perceptions by physicians and nursing staff of intensive care unit end-of-life decisions. Am J Respir Crit Care Med. 2003 May 15;167(10):1310-5. doi: 10.1164/rccm.200207-752OC. Epub 2003 Jan 24.

  • Ferrand E, Marty J; French LATASAMU Group. Prehospital withholding and withdrawal of life-sustaining treatments. The French LATASAMU survey. Intensive Care Med. 2006 Oct;32(10):1498-505. doi: 10.1007/s00134-006-0292-5. Epub 2006 Aug 2.

  • Prendergast TJ, Claessens MT, Luce JM. A national survey of end-of-life care for critically ill patients. Am J Respir Crit Care Med. 1998 Oct;158(4):1163-7. doi: 10.1164/ajrccm.158.4.9801108.

  • Sprung CL, Cohen SL, Sjokvist P, Baras M, Bulow HH, Hovilehto S, Ledoux D, Lippert A, Maia P, Phelan D, Schobersberger W, Wennberg E, Woodcock T; Ethicus Study Group. End-of-life practices in European intensive care units: the Ethicus Study. JAMA. 2003 Aug 13;290(6):790-7. doi: 10.1001/jama.290.6.790.

  • Ferrand E, Jabre P, Fernandez-Curiel S, Morin F, Vincent-Genod C, Duvaldestin P, Lemaire F, Herve C, Marty J. Participation of French general practitioners in end-of-life decisions for their hospitalised patients. J Med Ethics. 2006 Dec;32(12):683-7. doi: 10.1136/jme.2005.014084.

  • Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010 Aug 19;363(8):733-42. doi: 10.1056/NEJMoa1000678.

  • Kelley AS, Meier DE. Palliative care--a shifting paradigm. N Engl J Med. 2010 Aug 19;363(8):781-2. doi: 10.1056/NEJMe1004139. No abstract available.

  • Greer JA, Pirl WF, Jackson VA, Muzikansky A, Lennes IT, Heist RS, Gallagher ER, Temel JS. Effect of early palliative care on chemotherapy use and end-of-life care in patients with metastatic non-small-cell lung cancer. J Clin Oncol. 2012 Feb 1;30(4):394-400. doi: 10.1200/JCO.2011.35.7996. Epub 2011 Dec 27.

  • Yoong J, Park ER, Greer JA, Jackson VA, Gallagher ER, Pirl WF, Back AL, Temel JS. Early palliative care in advanced lung cancer: a qualitative study. JAMA Intern Med. 2013 Feb 25;173(4):283-90. doi: 10.1001/jamainternmed.2013.1874.

Study Officials

  • Edouard Ferrand, MD

    e.ferrand@hopital-foch.org

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 17, 2016

First Posted

September 20, 2016

Study Start

November 1, 2013

Primary Completion

March 1, 2019

Study Completion

March 1, 2019

Last Updated

May 17, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share

Locations